3D firm buys tumor-imaging tech

Article

Medical Media Systems has purchased the assets of GHRL, a Cambridge, MA, provider of validated industry-standard technology for 3D imaging of tumors. As part of the purchasing agreement, the West Lebanon, NH, provider of remote 3D medical imaging and

Medical Media Systems has purchased the assets of GHRL, a Cambridge, MA, provider of validated industry-standard technology for 3D imaging of tumors. As part of the purchasing agreement, the West Lebanon, NH, provider of remote 3D medical imaging and treatment planning applications will also sponsor a National Cancer Institute-funded clinical study to examine whether tumor volume is a better indicator of changes in tumor size and growth than the 2D-based RECIST (response evaluation criteria in solid tumors) protocol that measures the longest diameters of target lesions. The retrospective study, scheduled to begin in early 2004, will be conducted with the Dana Farber Cancer Institute and Harvard Medical School-affiliated hospitals.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.